Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12618046 | Generation of tumor immunity using astrocytes and astrocyte-dendritic cell combinations | 🖼🧊📄§ | 2026-05-05 | 2043-03-28 | 0 | 31 |
| 12618045 | Automated method for preparing retinal pigment epithelium cells | 🖼🧊📄§ | 2026-05-05 | 2040-06-19 | 0 | 31 |
| 12618063 | Pan-genotypic agents against influenza virus and methods of using the same | 🖼🧊📄§ | 2026-05-05 | 2044-07-16 | 0 | 31 |
| 12618076 | Methods of engineering platelets for targeting circulating tumor cells | 🖼🧊📄§ | 2026-05-05 | 2040-09-30 | 0 | 31 |
| 12618082 | Engineered muscle targeting compositions | 🖼🧊📄§ | 2026-05-05 | 2042-03-29 | 0 | 31 |
| 12617791 | Triheterocyclic derivative, and pharmaceutical composition and application thereof | 🖼🧊📄§ | 2026-05-05 | 2041-10-15 | 0 | 31 |
| 12617792 | Purine derivative, intermediate and application thereof in preparing anticancer medicine | 🖼🧊📄§ | 2026-05-05 | 2040-10-21 | 0 | 31 |
| 12617757 | Compounds and modules for inhibition of pre-miR-21 and their use in treatment of certain cancers | 🖼🧊📄§ | 2026-05-05 | 2040-10-29 | 0 | 31 |
| 12617762 | Carboxy derivatives with antiinflamatory properties | 🖼🧊📄§ | 2026-05-05 | 2040-12-23 | 0 | 31 |
| 12617790 | Mitragynine analogs and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-06-24 | 0 | 31 |
| 12617805 | Codrug that disintegrates in intestine, preparation therefor, and use thereof | 🖼🧊📄§ | 2026-05-05 | 2041-07-19 | 0 | 31 |
| 12617812 | Platinum(IV) complexes, methods of manufacture, compositions containing, and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2042-05-25 | 0 | 31 |
| 12617807 | Long lasting opioid reversal using hydrogen peroxide-induced release in blood | 🖼🧊📄§ | 2026-05-05 | 2042-04-01 | 0 | 31 |
| 12617820 | Engineered coronavirus spike (s) protein and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2041-05-28 | 0 | 31 |
| 12617828 | Genetically modified immune cell, preparation method therefor, and application | 🖼🧊📄§ | 2026-05-05 | 2040-05-06 | 0 | 31 |
| 12617826 | CLEC2 fusion protein and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-09-29 | 0 | 31 |
| 12617831 | Peptide targeting GIP and GLP-2 receptors for treating bone disorders | 🖼🧊📄§ | 2026-05-05 | 2040-02-21 | 0 | 31 |
| 12617836 | Tumor environment specific expression of effector genes | 🖼🧊📄§ | 2026-05-05 | 2042-03-21 | 0 | 31 |
| 12617841 | Nucleic acid antibody constructs for use against respiratory syncytial virus | 🖼🧊📄§ | 2026-05-05 | 2039-01-31 | 0 | 31 |
| 12617843 | Human broadly neutralizing antibodies against the membrane-proximal external region of HIV Env for vaccine design and intervention | 🖼🧊📄§ | 2026-05-05 | 2040-10-14 | 0 | 31 |
| 12617850 | Treatment of PD-L1-positive melanoma using an anti-PD-1 antibody | 🖼🧊📄§ | 2026-05-05 | 2042-03-22 | 0 | 31 |
| 12617849 | Antigen specific CD19-targeted CAR-T cells | 🖼🧊📄§ | 2026-05-05 | 2040-04-29 | 0 | 31 |
| 12617856 | Protease-cleavable substrates and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2045-03-17 | 0 | 31 |
| 12617870 | Methods of reversing ticagrelor activity | 🖼🧊📄§ | 2026-05-05 | 2039-09-20 | 0 | 31 |
| 12617864 | Methods of activating and proliferating exhausted CD8 T cells, CD8 T cells with enhanced activity prepared by the same, and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2042-04-12 | 0 | 31 |
| 12617866 | Humanized antibodies to mucin-16 and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2040-05-07 | 0 | 31 |
| 12617862 | Anti-CD73 antibody and application thereof | 🖼🧊📄§ | 2026-05-05 | 2040-08-20 | 0 | 31 |
| 12617846 | Subcutaneous (SC) administration of anti-C5 antibodies for treatment of complement-associated conditions | 🖼🧊📄§ | 2026-05-05 | 2041-05-06 | 0 | 31 |
| 12617857 | Chemokine receptor 4 (CXCR4) antagonist antibodies | 🖼🧊📄§ | 2026-05-05 | 2041-04-22 | 0 | 31 |
| 12617827 | Self-assembling peptide | 🖼🧊📄§ | 2026-05-05 | 2041-07-29 | 0 | 31 |
| 12616683 | Combination therapy for the treatment of gastrointestinal stromal tumors | 🖼🧊📄§ | 2026-05-05 | 2044-04-10 | 0 | 31 |
| 12616704 | Cannabichromene formulation for pain management | 🖼🧊📄§ | 2026-05-05 | 2041-03-31 | 0 | 31 |
| 12617835 | Chimeric autoantibody receptor (CAAR) that binds autoantibodies targeting the central nervous system in neurological autoimmune disease | 🖼🧊📄§ | 2026-05-05 | 2040-06-05 | 0 | 31 |
| 12616661 | Composition for type II diabetics and for use in providing sustained energy release over time | 🖼🧊📄§ | 2026-05-05 | 2039-03-07 | 0 | 31 |
| 12616755 | Antifungal quercetin conjugates, methods of preparation and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2045-10-08 | 0 | 31 |
| 12616652 | Lenses for treating ocular diseases and preparation method thereof | 🖼🧊📄§ | 2026-05-05 | 2042-12-29 | 0 | 31 |
| 12616745 | Influenza virus backbone | 🖼🧊📄§ | 2026-05-05 | 2040-06-05 | 0 | 31 |
| 12616749 | Methods for treatment of psoriasis with an anti-oxLDL antibody | 🖼🧊📄§ | 2026-05-05 | 2044-06-21 | 0 | 31 |
| 12616782 | Use of mitochondria to treat and/or prevent tendon injury or its related disease | 🖼🧊📄§ | 2026-05-05 | 2041-03-19 | 0 | 31 |
| 12616721 | Stratified squamous epithelial cell normal differentiation and maturation promoting agent, epithelial disease therapeutic agent, and stratified squamous epithelial cell normal differentiation and maturation promoting method | 🖼🧊📄§ | 2026-05-05 | 2039-01-11 | 0 | 31 |
| 12616696 | Crystalline forms of (p)-3-chloro-4-((3,5-difluoropyridin-2-yl)methoxy)-2′-(2-(2-hydroxypropan-2-yl)pyrimidin-4-yl)-5′,6-dimethyl-2h-[1,4′-bipyridin]-2-one | 🖼🧊📄§ | 2026-05-05 | 2041-03-26 | 0 | 31 |
| 12616663 | Plant-derived exosome-like nanoparticles inhibit bacterial pathogenicity | 🖼🧊📄§ | 2026-05-05 | 2040-03-02 | 0 | 31 |
| 12617838 | Auto/allo-immune defense receptors for the selective targeting of activated pathogenic T cells and NK cells | 🖼🧊📄§ | 2026-05-05 | 2039-04-25 | 0 | 31 |
| 12617848 | Methods of treating ocular pathologies using bifunctional molecules that target growth factors | 🖼🧊📄§ | 2026-05-05 | 2041-11-08 | 0 | 31 |
| 12617834 | Composition of NY-ESO-1-specific t cell receptors restricted on multiple major histocompatibility complex molecules | 🖼🧊📄§ | 2026-05-05 | 2039-09-04 | 0 | 31 |
| 12617842 | Antiviral immunotherapy by membrane receptor ligation | 🖼🧊📄§ | 2026-05-05 | 2041-12-02 | 0 | 31 |
| 12617818 | Compositions and methods for modulating myosin subfragment-2 coiled coil stability and methods for using them | 🖼🧊📄§ | 2026-05-05 | 2041-03-25 | 0 | 31 |
| 12618067 | Targeted delivery of an inhibitor of miR-21 to macrophages for the treatment of pulmonary fibrosis | 🖼🧊📄§ | 2026-05-05 | 2041-04-09 | 0 | 31 |
| 12618840 | Antibody for detecting acetylation of COX2 protein, and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2040-09-18 | 0 | 31 |
| 12618839 | Antibodies for detecting Epstein Barr virus-positive gastric cancer | 🖼🧊📄§ | 2026-05-05 | 2040-10-23 | 0 | 31 |
Page 1Next →